Page last updated: 2024-10-27

fluconazole and Anorexia

fluconazole has been researched along with Anorexia in 3 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.

Research Excerpts

ExcerptRelevanceReference
"Efficacies of fluconazole, a new triazole antifungal agent, were evaluated in 11 cases of systemic mycoses (1 case each of candiduria, pulmonary cryptococcosis, pulmonary aspergillosis, pulmonary penicilliosis and suspected fungal pulmonary infection, and 3 cases each of candidemia and Candida endophthalmitis)."7.67[Fluconazole treatment of systemic mycoses]. ( Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K, 1989)
"Fluconazole, a novel triazole antifungal agent, was given orally or intravenously to 10 patients with pulmonary mycosis (7 patients with primary pulmonary cryptococcosis and 3 with pulmonary aspergillosis)."3.67[Clinical efficacy of fluconazole in the patient with pulmonary mycosis]. ( Hanawa, T; Hatakenaka, R; Ikeda, S; Katsura, A; Kosaba, S; Lee, Y; Matsubara, Y; Ninomiya, K; Shiota, T; Yagi, K, 1989)
"Efficacies of fluconazole, a new triazole antifungal agent, were evaluated in 11 cases of systemic mycoses (1 case each of candiduria, pulmonary cryptococcosis, pulmonary aspergillosis, pulmonary penicilliosis and suspected fungal pulmonary infection, and 3 cases each of candidemia and Candida endophthalmitis)."3.67[Fluconazole treatment of systemic mycoses]. ( Ebe, T; Hamamoto, T; Hibiya, I; Inagaki, M; Isonuma, H; Kohara, T; Matsumura, M; Mori, T; Takahashi, M; Watanabe, K, 1989)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, Y1
Shiota, T1
Ikeda, S1
Katsura, A1
Hanawa, T1
Yagi, K1
Kosaba, S1
Hatakenaka, R1
Matsubara, Y1
Ninomiya, K1
Mori, T1
Matsumura, M1
Ebe, T1
Takahashi, M1
Kohara, T1
Inagaki, M1
Isonuma, H1
Hibiya, I1
Hamamoto, T1
Watanabe, K1

Other Studies

3 other studies available for fluconazole and Anorexia

ArticleYear
Systemic antifungal drugs.
    The Medical letter on drugs and therapeutics, 1997, Sep-12, Volume: 39, Issue:1009

    Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom

1997
[Clinical efficacy of fluconazole in the patient with pulmonary mycosis].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antifungal Agents; Aspergillosis; Cr

1989
[Fluconazole treatment of systemic mycoses].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candidiasis; Drug Evaluation; Drug Tolerance;

1989